Download PDF
J Neurol Surg B Skull Base 2021; 82(06): 608-614
DOI: 10.1055/s-0040-1715809
Original Article

Regional Recurrences and Hyams Grade in Esthesioneuroblastoma

Hedyeh Ziai
1   Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada
,
Eugene Yu
2   Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada
,
Ilan Weinreb
3   Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
,
Bayardo Perez-Ordonez
3   Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
,
Christopher M. K. L. Yao
1   Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada
,
Wei Xu
4   Department of Biostatistics, the Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada
,
Dongyang Yang
4   Department of Biostatistics, the Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada
,
Ian J. Witterick
1   Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada
,
Eric Monteiro
1   Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada
,
Ralph W. Gilbert
1   Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada
,
Jonathan C. Irish
1   Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada
,
Patrick J. Gullane
1   Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada
,
David P. Goldstein
1   Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada
,
Jolie Ringash
5   Department of Radiation Oncology, the Princess Margaret Cancer Centre, Toronto, Ontario, Canada
,
Andrew Bayley
5   Department of Radiation Oncology, the Princess Margaret Cancer Centre, Toronto, Ontario, Canada
,
John R. de Almeida
1   Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Objective The aim of this study is to determine if Hyams grade may help predict which patients with esthesioneuroblastoma (ENB) tumors are likely to develop regional recurrences, and to determine the impact of tumor extent on regional failure in ENB patients without evidence of nodal disease at presentation.

Design The study was designed as a retrospective review for ENB patients.

Settings The study was prepared at tertiary care academic center for ENB patients.

Participants Patients with ENB were included in the study.

Main Outcome Measures  Oncologic outcomes (5-year regional and locoregional control (LRC) and overall survival) in patients with Hyams low grade versus high grade. Oncologic outcomes based on radiographic disease extent.

Results A total of 43 patients were included. Total 25 patients (58%) had Hyams low-grade tumor, and 18 (42%) had high-grade tumor. Of the 34 patients without regional disease at presentation, 8 (24%) were treated with elective nodal radiation. There were no statistically significant differences in 5-year regional control in the Hyams low-grade versus high-grade groups (78 vs. 89%; p = 0.4). The 5-year LRC rates in patients with low grade versus high grade were 73 versus 89% (p = 0.6). The 5-year overall survival rates in patients with low-grade versus high-grade tumors were 86 versus 63% (p = 0.1). Radiographic extension of disease into the olfactory groove, olfactory nerve, dura, and periorbita were statistically associated with decreased 5-year overall survival (5-year OS 49 vs. 91% [p = 0.04], 49 vs. 91% [p = 0.04], 44 vs. 92% [p = 0.02], and 44 vs. 80% [p = 0.04], respectively).

Conclusion ENBs are associated with a risk of regional failure. The current analysis suggests that Hyams low-grade and high-grade malignancies have comparable rates of early and delayed regional recurrences, although small sample size may limit our conclusions.

Keywords

head and neck - esthesioneuroblastoma - Hyams grade - regional failure - elective neck treatment - radiation - survival

Note

This work was presented at the 29th Annual North American Skull Base Society Meeting in Orlando, Florida, United States, February 15, 2019.




Publication History

Received: 11 December 2019

Accepted: 02 June 2020

Article published online:
05 October 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Su SY, Bell D, Hanna EY. Esthesioneuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma: differentiation in diagnosis and treatment. Int Arch Otorhinolaryngol 2014; 18 (Suppl. 02) S149-S156
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Peacock JG, Harmsen WS, Link MJ. et al. Risk of delayed lymph node metastasis in clinically N0 esthesioneuroblastoma. J Neurol Surg B Skull Base 2017; 78 (01) 68-74
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Howell MC, Branstetter IV BF, Snyderman CH. Patterns of regional spread for esthesioneuroblastoma. AJNR Am J Neuroradiol 2011; 32 (05) 929-933
    CrossrefPubMedGoogle Scholar
  • 4 Argiris A, Dutra J, Tseke P, Haines K. Esthesioneuroblastoma: the Northwestern University experience. Laryngoscope 2003; 113 (01) 155-160
    CrossrefPubMedGoogle Scholar
  • 5 Demiroz C, Gutfeld O, Aboziada M, Brown D, Marentette LJ, Eisbruch A. Esthesioneuroblastoma: is there a need for elective neck treatment?. Int J Radiat Oncol Biol Phys 2011; 81 (04) e255-e261
    CrossrefPubMedGoogle Scholar
  • 6 Rimmer J, Lund VJ, Beale T, Wei WI, Howard D. Olfactory neuroblastoma: a 35-year experience and suggested follow-up protocol. Laryngoscope 2014; 124 (07) 1542-1549
    CrossrefPubMedGoogle Scholar
  • 7 Beitler JJ, Fass DE, Brenner HA. et al. Esthesioneuroblastoma: is there a role for elective neck treatment?. Head Neck 1991; 13 (04) 321-326
    CrossrefPubMedGoogle Scholar
  • 8 Gore MR, Zanation AM. Salvage treatment of late neck metastasis in esthesioneuroblastoma: a meta-analysis. Arch Otolaryngol Head Neck Surg 2009; 135 (10) 1030-1034
    CrossrefPubMedGoogle Scholar
  • 9 Simon JH, Zhen W, McCulloch TM. et al. Esthesioneuroblastoma: the University of Iowa experience 1978-1998. Laryngoscope 2001; 111 (03) 488-493
    CrossrefPubMedGoogle Scholar
  • 10 Zanation AM, Ferlito A, Rinaldo A. et al. When, how and why to treat the neck in patients with esthesioneuroblastoma: a review. Eur Arch Otorhinolaryngol 2010; 267 (11) 1667-1671
    CrossrefPubMedGoogle Scholar
  • 11 Resto VA, Eisele DW, Forastiere A, Zahurak M, Lee DJ, Westra WH. Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck 2000; 22 (06) 550-558
    CrossrefPubMedGoogle Scholar
  • 12 Martel J, Darrouzet V, Duclos JY, Bébéar JP, Stoll D. [Olfactory esthesioneuromas]. Rev Laryngol Otol Rhinol (Bord) 2000; 121 (04) 227-236
    PubMedGoogle Scholar
  • 13 Kaur G, Kane AJ, Sughrue ME. et al. The prognostic implications of Hyam's subtype for patients with Kadish stage C esthesioneuroblastoma. J Clin Neurosci 2013; 20 (02) 281-286
    CrossrefPubMedGoogle Scholar
  • 14 Bachar G, Goldstein DP, Shah M. et al. Esthesioneuroblastoma: The Princess Margaret Hospital experience. Head Neck 2008; 30 (12) 1607-1614
    CrossrefPubMedGoogle Scholar
  • 15 Malouf GG, Casiraghi O, Deutsch E, Guigay J, Temam S, Bourhis J. Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome. Eur J Cancer 2013; 49 (06) 1324-1334
    CrossrefPubMedGoogle Scholar
  • 16 Ozsahin M, Gruber G, Olszyk O. et al. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study. Int J Radiat Oncol Biol Phys 2010; 78 (04) 992-997
    CrossrefPubMedGoogle Scholar
  • 17 Hyams VJ. Olfactory neuroblastoma (Case 6). In: Batsakis JG, Hyams VJ, Morales AR. eds. Special Tumors of the Head and Neck. Chicago: ASCP Press; 1982: 24-29
    Google Scholar
  • 18 Kane AJ, Sughrue ME, Rutkowski MJ. et al. Posttreatment prognosis of patients with esthesioneuroblastoma. J Neurosurg 2010; 113 (02) 340-351
    CrossrefPubMedGoogle Scholar
  • 19 Van Gompel JJ, Giannini C, Olsen KD. et al. Long-term outcome of esthesioneuroblastoma: hyams grade predicts patient survival. J Neurol Surg B Skull Base 2012; 73 (05) 331-336
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Dias FL, Sa GM, Lima RA. et al. Patterns of failure and outcome in esthesioneuroblastoma. Arch Otolaryngol Head Neck Surg 2003; 129 (11) 1186-1192
    CrossrefPubMedGoogle Scholar
  • 21 Gallagher KK, Spector ME, Pepper JP, McKean EL, Marentette LJ, McHugh JB. Esthesioneuroblastoma: updating histologic grading as it relates to prognosis. Ann Otol Rhinol Laryngol 2014; 123 (05) 353-358
    CrossrefPubMedGoogle Scholar
  • 22 Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: prognosis and management. Neurosurgery 1993; 32 (05) 706-714 , discussion 714–715
    CrossrefPubMedGoogle Scholar
  • 23 Fukushima S, Sugita Y, Niino D, Mihashi H, Ohshima K. Clincopathological analysis of olfactory neuroblastoma. Brain Tumor Pathol 2012; 29 (04) 207-215
    CrossrefPubMedGoogle Scholar
  • 24 Bell D, Saade R, Roberts D. et al. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol 2015; 9 (01) 51-59
    CrossrefPubMedGoogle Scholar
  • 25 Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 1976; 37 (03) 1571-1576
    CrossrefPubMedGoogle Scholar
  • 26 Dulguerov P, Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope 1992; 102 (08) 843-849
    CrossrefPubMedGoogle Scholar
  • 27 Naples JG, Spiro J, Tessema B, Kuwada C, Kuo CL, Brown SM. Neck recurrence and mortality in esthesioneuroblastoma: Implications for management of the N0 neck. Laryngoscope 2016; 126 (06) 1373-1379
    CrossrefPubMedGoogle Scholar
  • 28 Goshtasbi K, Abiri A, Abouzari M. et al. Hyams grading as a predictor of metastasis and overall survival in esthesioneuroblastoma: a meta-analysis. Int Forum Allergy Rhinol 2019; 9 (09) 1054-1062
    CrossrefPubMedGoogle Scholar
  • 29 Li R, Tian S, Zhu Y. et al. Management of orbital invasion in esthesioneuroblastoma: 14 years' experience. Radiat Oncol 2019; 14 (01) 107
    CrossrefPubMedGoogle Scholar
  • 30 Monroe AT, Hinerman RW, Amdur RJ, Morris CG, Mendenhall WM. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation. Head Neck 2003; 25 (07) 529-534
    CrossrefPubMedGoogle Scholar
  • 31 Hollen TR, Morris CG, Kirwan JM. et al. Esthesioneuroblastoma of the nasal cavity. Am J Clin Oncol 2015; 38 (03) 311-314
    CrossrefPubMedGoogle Scholar
  • 32 Koka VN, Julieron M, Bourhis J. et al. Aesthesioneuroblastoma. J Laryngol Otol 1998; 112 (07) 628-633
    CrossrefPubMedGoogle Scholar
  • 33 Yin ZZ, Luo JW, Gao L. et al. Spread patterns of lymph nodes and the value of elective neck irradiation for esthesioneuroblastoma. Radiother Oncol 2015; 117 (02) 328-332
    CrossrefPubMedGoogle Scholar
  • 34 Modesto A, Blanchard P, Tao YG. et al. Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma. Oral Oncol 2013; 49 (08) 830-834
    CrossrefPubMedGoogle Scholar
  • 35 Noh OK, Lee SW, Yoon SM. et al. Radiotherapy for esthesioneuroblastoma: is elective nodal irradiation warranted in the multimodality treatment approach?. Int J Radiat Oncol Biol Phys 2011; 79 (02) 443-449
    CrossrefPubMedGoogle Scholar
  • 36 Kim JW, Kong IG, Lee CH. et al. Expression of Bcl-2 in olfactory neuroblastoma and its association with chemotherapy and survival. Otolaryngol Head Neck Surg 2008; 139 (05) 708-712
    CrossrefPubMedGoogle Scholar
  • 37 Oberländer M, Alkemade H, Bünger S. et al. A ‘waterfall’ transfer-based workflow for improved quality of tissue microarray construction and processing in breast cancer research. Pathol Oncol Res 2014; 20 (03) 719-726
    CrossrefPubMedGoogle Scholar